OakChart

Concentra Group Holdings Parent Inc

CONHealthcare·Medical Care Facilities·USA·Mid·NYSE·Nov 11 • 9:18 AM ET

41.81-0.86 (-2.02%)
2026-11-11 15:28 CET
Market cap
5,398.52 USD m
Revenue, TTM
2,336.79 USD m
Net income, TTM
211.85 USD m
Free cash flow, TTM
257.40 USD m
EPS diluted, TTM
1.66
P/E
25.24
Compare

Price

CON against its 20, 50 and 200-day averages
2050200beat
30.0040.002.4M4.9MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26CONclose 41.8120-day 40.5350-day 37.50200-day 29.3041.81

5.5% under 44.22 on 5 Nov 2026. Last 15 sessions, 13.6% high to low

Profile

CON
52-week range, 90% of the way up
18.9644.22

Concentra Group Holdings Parent, Inc. provides occupational health services. The firm operates through the following segments: Occupational Health Centers, Onsite Health Clinics and Other Businesses. The Occupational Health Centers segment provides occupational health services at 547 health center facilities across the United States. The Onsite Health Clinics segment delivers occupational health services and/or employer-sponsored primary care services at an employer's workplace. The Other Businesses segment consists of several complementary services to core occupational health services offering and includes Concentra Telemed, Concentra Pharmacy and Concentra Medical Compliance Administration. The company was founded in 1979 is headquartered in Addison, TX.

IndexRUT
Employees13133
IPOJul 25, 2024
Beta0.48
ATR, 14d1.28
Rel volume0.02
Short float1.93%
Insider own6.99%
Inst own89.42%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap5.29B
Enterprise Value7.36B
Income211.85M
Sales2.34B
Book/sh4.01
Cash/sh0.68
Dividend Est.0.15 (0.37%)
Dividend TTM0.25 (0.59%)
Dividend Ex-DateNov 19, 2026
Dividend Gr. 3/5Y- -
Payout19.54%
Employees13133
IPOJul 25, 2024

Ratios

P/E25.24
Forward P/E22.07
PEG1.43
P/S2.26
P/B10.43
P/C61.64
P/FCF20.55
EV/EBITDA15.33
EV/Sales3.15
Quick Ratio1.30
Current Ratio1.30
Debt/Eq4.20
LT Debt/Eq4.00
Option/ShortYes / Yes

Earnings

EPS (ttm)1.66
EPS next Y1.89
EPS next Q0.30
EPS this Y24.75%
EPS next Y10.85%
EPS next 5Y15.46%
EPS past 3/5Y-0.96% -6.16%
Sales past 3/5Y7.85% 5.72%
EPS Y/Y TTM40.63%
Sales Y/Y TTM11.84%
EPS Q/Q36.40%
Sales Q/Q8.61%
EarningsNov 05 AMC
EPS/Sales Surpr.18.29% 2.74%

Ownership

Insider Own6.99%
Insider Trans-5.55%
Inst Own89.42%
Inst Trans2.14%
ROA7.26%
ROE47.63%
ROIC8.38%
Gross Margin26.48%
Oper. Margin17.13%
Profit Margin9.07%
SMA203.15%
SMA5011.50%
SMA20042.68%
Trades-

Technical

Shs Outstand126.52M
Shs Float117.68M
Short Float1.93%
Short Ratio2.11
Short Interest2.27M
52W High44.22 -5.45%
52W Low18.96 120.52%
Volatility4.71% 3.04%
ATR (14)1.28
RSI (14)61.53
Beta0.48
Rel Volume0.02
Avg Volume1.07M
Volume964

Performance

Perf Week-4.02%
Perf Month11.37%
Perf Quarter19.05%
Perf Half Y61.62%
Perf YTD112.45%
Perf Year113.53%
Perf 3Y-
Perf 5Y-
Perf 10Y-
Recom1.00
Target Price45.90
Prev Close42.67
Price41.81
Change %-2.02%

Analyst ratings

latest 10 of 15
DateActionAnalystRating changeTargetImplied
Oct 20, 2026InitiatedSStephensOverweight$45+7.6%
Oct 16, 2026InitiatedJJefferiesBuy$47+12.4%
Jul 01, 2026InitiatedWWilliam BlairOutperform
Jun 05, 2026InitiatedGGoldmanBuy$30-28.2%
Sep 18, 2025ResumedJJP MorganOverweight$31-25.9%
Dec 16, 2024UpgradeBBofA SecuritiesNeutral → Buy$24-42.6%
Oct 07, 2024DowngradeBBofA SecuritiesBuy → Neutral$30.50 → $24-42.6%
Aug 20, 2024InitiatedRRBC Capital MktsOutperform$33-21.1%
Aug 19, 2024InitiatedWWells FargoOverweight$27-35.4%
Aug 19, 2024InitiatedTTruistBuy$29-30.6%

Peers

Mkt cap
TickerCompanyMkt cap
USPHU.S. Physical Therapy Inc1.48B
ASTHAstrana Health Inc1.73B
EHCEncompass Health Corp13.95B
SGRYSurgery Partners Inc3.46B
MDPediatrix Medical Group Inc2.42B
CRVLCorvel Corp4.28B
JYNTJoint Corp93.50M
DGXQuest Diagnostics Inc28.43B
PRVAPrivia Health Group Inc3.13B
LHLabcorp Holdings Inc30.11B

Insider trading

11 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
ORTENZIO ROBERT ADirectorAug 03 '26Sale31.84130,0004,139,356503,455Aug 05 04:31 PM
ORTENZIO ROBERT ADirectorAug 03 '26Proposed Sale31.65130,0004,114,500Aug 03 04:09 PM
ORTENZIO ROBERT ADirectorJul 01 '26Sale30.50130,0003,964,597633,455Jul 06 04:05 PM
ORTENZIO ROBERT ADirectorJul 01 '26Proposed Sale40.69389,94015,865,323Jul 01 04:45 PM
ORTENZIO ROBERT ADirectorJun 30 '26Proposed Sale29.4194427,763Jun 30 04:19 PM
ORTENZIO ROBERT ADirectorJun 29 '26Proposed Sale29.855,589166,832Jun 29 04:04 PM
ORTENZIO ROBERT ADirectorJun 26 '26Proposed Sale29.6453,5271,586,540Jun 26 04:22 PM
ORTENZIO ROBERT ADirectorJun 01 '26Sale25.00130,0003,250,026763,455Jun 02 04:29 PM
ORTENZIO ROBERT AChairmanJun 01 '26Proposed Sale25.00130,0003,250,000Jun 01 04:17 PM
ORTENZIO ROBERT ADirectorMay 08 '26Sale25.00130,0003,250,000893,455May 11 05:01 PM
ORTENZIO ROBERT AChairmanMay 08 '26Proposed Sale25.00130,0003,250,000May 08 04:15 PM

Held by

AUM
TickerCompanyAUM
IJRiShares Core S&P Small-Cap ETFAUM: 106.27B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
VBRVanguard Morningstar Small-Cap Value ETFAUM: 37.76B
DFASU.S. Small Cap Portfolio-ETF Class Shares-
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
SPSMState Street SPDR Portfolio S&P 600TM Small Cap ETFAUM: 16.06B
VXFVanguard Extended Market Index ETFAUM: 30.47B
XSMOInvesco S&P SmallCap Momentum ETFAUM: 2.74B

News

latest 14 of 206
  • Concentra Beats And Raises For A Third Straight Quarter As Volume Replaces Pricing As The Growth Engine (Earnings Whispers)
  • Concentra: Q3 Earnings Snapshot (Associated Press)
  • Concentra Announces Results For Its Third Quarter Ended September 30, 2026 and Raises FY 2026 Guidance (Business Wire)
  • Concentra Tests Record Margins And A Near Breakout As New CEO Takes Over (Earnings Whispers)
  • Concentra to Announce Third Quarter 2026 Results on Thursday, November 5, 2026 (Business Wire)
  • Loading…
  • Concentra Expands Florida Footprint with New Daytona Beach Medical Center (Business Wire)
  • Concentra Appoints Tanner Newton Chief Financial Officer (Business Wire)
  • Concentra Appoints Dr. Jill Rosenthal as Chief Medical Officer to Advance Clinical Innovation and Workforce Health (Business Wire)
  • Concentra Strengthens Workforce Health Access in Minnesota Through Acquisition (Business Wire)
  • Concentra to Present at Upcoming Investor Conferences (Business Wire)
  • Concentra Group Holdings Parent Inc (CON) (Q2 2026) Earnings Call Highlights: Strong Revenue ... (GuruFocus.com) +11.53%
  • Concentra: Q2 Earnings Snapshot (Associated Press)
  • Concentra Group Holdings Parent, Inc. Announces Results For Its Second Quarter Ended June 30, 2026 and Raises FY 2026 Guidance (Business Wire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-050.5200.4400.520622.12605.5211
2026Q22026-08-060.5200.4220.500606.03591.759
2026Q12026-05-070.4000.3380.385569.56553.536
2025Q42026-02-260.2800.2350.264539.08533.297
2025Q32025-11-060.3900.3750.372572.8562.697
2025Q22025-08-070.3500.3800.344550.8537.357
2025Q12025-05-070.3000.3160.307500.8496.468
2024Q42025-03-030.1700.1660.168465.04464.058
2024Q32024-10-310.3700.3550.348489.64492.618
2024Q22024-08-280.4980.4980.409471.92473.667
2024Q12024-05-290.479-0.387467.77--
2026Q4--0.298--573.3411
2027Q1--0.453--606.599
2027Q2--0.559--641.189
2027Q3--0.562--657.368
2027Q4--0.344--603.987

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2024FY1.4601.4531.3001,9001,900
2025FY1.3701.3211.3002,1632,157
2026FY-1.709--2,365
2027FY-1.895--2,505
2028FY-2.109--2,659

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-091120573.34570577.63
2026Q4S2026-11-061120573.22570577.63
2026Q4S2026-11-051100572.11565.36577.72
2026Q4S2026-10-211100572.11565.36577.72
2026Q4S2026-10-161110572.11565.36577.72
2026Q4S2026-10-141010572.25565.36577.72
2026Q4S2026-09-17910571.78565.36577.72
2026Q4S2026-09-09910571.74565.36577.72
2026Q4S2026-08-29810571.96565.36577.72
2026Q4S2026-08-11910571.71565.36577.72
2026Q4S2026-08-10910571.26565.36577.72
2026Q4S2026-08-07910570.81565.36577.72
2026Q4S2026-07-13900569.28565.57573
2026Q4S2026-07-10900569.29565.57573.1

Estimate history

EPS, annual1.651.3171.4221.31.281.6566
Period20212022202320242025TTM
EPS, quarterly0.3480.1680.3070.3440.3720.2640.3850.50.507
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual1732.0411724.3591838.0811900.1922163.4172336.79
Period20212022202320242025TTM
Sales, quarterly489.638465.041500.752550.785572.8539.08569.555606.03622.122
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual126.594126.594126.594128.126128.633126.518
Period20212022202320242025MRQ
Shares, quarterly127.344128.126128.172128.171128.17128.633127.962127.518126.518
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY
Total Revenue2,336.792,163.421,900.191,838.081,724.361,732.04
Cost of Goods Sold Incl. D&A1,718.011,626.141,439.391,398.701,316.171,304.06
Gross Profit618.77537.28460.80439.38408.19427.98
Selling, General and Administrative Excl. Other218.48191.74156.32152.00149.98157.71
Other Operating Expense0.000.000.000.000.000.00
Operating Income400.30345.54304.48287.38258.22270.26
Interest Expense117.31110.3169.6944.4731.6431.86
Unusual Expense-8.7311.420.000.00--
Net Income Before Taxes291.78223.83231.39242.63224.90275.56
Income Taxes68.2350.9859.5057.8952.6559.53
Consolidated Net Income219.73172.85171.90184.74172.24216.04
Net Income From Continuing Operations212.53166.41166.54179.95166.73208.88
Net Income211.85164.17166.54179.95166.73208.88
EPS (Recurring)1.621.341.301.421.321.65
EPS (Basic, Before Extraordinaries)1.691.301.301.421.321.65
EPS (Diluted)1.661.281.301.421.321.65
EBITDA480.29421.35371.66360.43331.88352.48
Non-Operating Income (Expense)0.070.02-3.39-0.28-1.6837.15
Other After Tax Adjustments-3.830.000.000.000.000.00
Stock Option Compensation Expense12.978.291.840.511.691.56
Price To Earnings Ratio25.7625.76----
Price To Sales Ratio1.871.171.33---
Gross Margin26.4824.8324.2523.9023.6724.71
Operating Margin17.1315.9716.0215.6314.9715.60
Net Margin9.077.598.769.799.6712.06
Shares Outstanding126.52128.63128.13126.59126.59126.59
Market Capitalization5,398.525,398.522,518.862,560.89--

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue622.12606.03569.55539.08572.80550.78500.75465.04
Cost of Goods Sold Incl. D&A446.80433.83418.73418.64425.44408.33373.72360.46
Gross Profit175.32172.20150.82120.44147.36142.45127.03104.58
Selling, General and Administrative Excl. Other60.5954.8453.9849.0650.6848.7443.2645.49
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income114.73117.3696.8471.3796.6893.7283.7759.09
Interest Expense28.7328.2528.5731.7629.4425.7423.3726.44
Unusual Expense-3.33-0.83-1.38-3.181.456.646.510.00
Net Income Before Taxes90.0489.3469.6142.7965.7961.3553.9032.65
Income Taxes22.2722.0517.326.6015.9715.1513.259.85
Consolidated Net Income66.3865.9351.2336.1949.8246.1940.6422.80
Net Income From Continuing Operations64.5063.9349.4234.6948.2644.5638.9121.51
Net Income64.5063.9349.4234.0047.6944.0338.9121.51
EPS (Recurring)0.490.500.380.250.380.380.340.17
EPS (Basic, Before Extraordinaries)0.520.510.390.260.380.350.310.17
EPS (Diluted)0.510.500.380.260.370.340.310.17
EBITDA134.88137.26116.4891.66116.59112.71100.3974.70
Non-Operating Income (Expense)0.70-0.59-0.040.000.000.020.000.00
Other After Tax Adjustments-1.39-1.37-1.060.000.000.000.000.00
Stock Option Compensation Expense3.593.263.272.851.841.811.791.44
Price To Earnings Ratio25.7621.8016.6716.5317.9416.7016.55-
Price To Sales Ratio1.871.661.231.171.281.311.421.33
Gross Margin28.1828.4126.4822.3425.7325.8625.3722.49
Operating Margin18.4419.3717.0013.2416.8817.0116.7312.71
Net Margin10.3710.558.686.318.337.997.774.63
Shares Outstanding126.52127.52127.96128.63128.17128.17128.17128.13
Market Capitalization5,398.523,806.872,759.222,522.392,682.622,636.502,781.332,518.86

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY
Cash & Short Term Investments79.90183.2531.3737.66-
Short Term Receivables257.90217.72216.19206.26-
Inventories0.000.000.000.00-
Other Current Assets45.3036.2346.8540.71-
Total Current Assets383.10437.21294.42284.63-
Net Property, Plant & Equipment708.96633.52576.22533.93-
Total Investments and Advances0.000.000.000.00-
Intangible Assets1,721.751,439.431,454.511,473.45-
Deferred Tax Assets203.89182.10154.21143.92-
Other Assets20.466.598.415.24-
Total Assets3,038.162,698.862,487.772,441.16-
Short Term Debt Incl. Current Port. of LT Debt95.3285.5374.4072.97-
Accounts Payable21.0019.7520.4127.67-
Income Tax Payable0.832.350.400.05-
Other Current Liabilities220.09199.55179.42178.94-
Total Current Liabilities337.25307.19274.63279.63-
Long Term Debt2,007.301,865.83830.60966.68-
Provision for Risks Charges0.000.000.000.00-
Deferred Tax Liabilities228.68203.07177.57173.72-
Other Liabilities44.5124.0427.5225.02-
Total Liabilities2,617.732,400.131,310.331,445.04-
Non-Equity Reserves0.000.000.000.00-
Preferred Stock - Carrying Value0.000.000.000.00-
Common Equity393.28275.671,155.60973.32-
Total Shareholders Equity393.28275.671,155.60973.32-
Accumulated Minority Interest27.1523.0521.8422.80-
Total Equity420.43298.721,177.44996.12-
Total Liabilities & Stockholders Equity3,038.162,698.862,487.772,441.16-
Book Value Per Share3.062.159.137.69-
Tangible Book Value Per Share-10.33-9.08-2.36-3.95-
Full-Time Employees13,13311,25011,320--
Price to Book Ratio10.659.079.22--
Return on Assets5.806.427.30--
Return on Equity49.7523.2716.91--
Return on Invested Capital6.937.789.068.59-
Quick Ratio1.141.421.071.02-
Current Ratio1.141.421.071.02-

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY
Net Income223.55172.85171.90184.74172.24216.04
Depreciation79.9975.8267.1873.0573.6782.21
Other Funds (Non Cash)21.2614.887.821.513.151.00
Funds from Operations320.43271.44244.50253.02240.42297.92
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital6.367.9630.18-18.7033.92-7.28
Cash from Operating Activities326.79279.40274.68234.32274.34290.64
Capital Expenditures-69.39-82.33-64.33-69.34-45.98-46.79
Net Assets From Acquisitions-9.99-333.30-6.96-6.00-9.70-20.10
Sale of Fixed Assets and Businesses4.330.780.030.046.869.38
Purchase or Sale of Investments0.000.000.000.00-2.100.00
Purchase of Investments0.000.000.000.00-2.100.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-75.06-414.86-71.27-75.31-50.93-57.51
Cash Dividends Paid-32.02-32.08-1,543.64-6.13-6.29-6.71
Change in Capital Stock-83.03-22.42495.80-1.98-25.71-13.27
Repurchase of Common Pref Stock-83.03-22.42-15.40-5.32-29.05-23.40
Sale of Common Pref Stock0.000.00511.203.343.3410.13
Proceedsfrom Stock Options0.000.00511.200.000.000.00
Issuance or Reduction of Debt, Net-96.0590.39999.95-161.69-184.68-326.89
Change in Long Term Debt-96.0590.391,469.95-1.69-34.68-326.89
Issuance of Long Term Debt4.911,040.421,482.265.474.260.00
Reduction of Long Term Debt-100.97-950.04-12.31-7.17-38.95-326.89
Net Financing Active Other Cash Flow-4.75-3.78-3.634.510.000.00
Other Financing Activities Uses-7.62-6.65-5.910.000.000.00
Cash from Financing Activities-215.8632.10-51.53-165.29-216.68-346.88
Net Change in Cash35.88-103.36151.88-6.286.73-113.75
Free Cash Flow257.40197.06210.35164.98228.35243.85
Preferred Dividends (Cash Flow)--0.000.000.000.00
Price to Free Cash Flow19.4115.30----
Deferred Taxes & Investment Tax Credit-7.89-2.40-6.29-8.64-1.33

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments85.82158.0461.7079.9049.9473.87
Short Term Receivables320.26299.82296.51257.90278.97271.75
Inventories0.000.000.000.000.000.00
Other Current Assets53.5848.6346.0145.3046.5249.54
Total Current Assets459.66506.48404.21383.10375.44395.17
Net Property, Plant & Equipment798.11748.46724.54708.96711.45693.61
Total Investments and Advances2.030.470.000.000.000.00
Intangible Assets1,710.731,712.691,719.071,721.751,732.951,737.91
Deferred Tax Assets24.7522.5121.51203.89--
Other Assets16.3519.6720.4320.4624.1014.89
Total Assets3,011.643,010.282,889.763,038.162,843.932,841.58
Short Term Debt Incl. Current Port. of LT Debt99.5499.6298.9295.3295.7497.20
Accounts Payable34.5536.4131.7421.0032.7938.88
Income Tax Payable2.086.8616.510.831.151.13
Other Current Liabilities216.80225.04173.71220.09182.97197.86
Total Current Liabilities352.98367.94320.88337.25312.65335.07
Long Term Debt2,028.912,044.202,023.712,007.302,042.342,082.44
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities48.6347.0847.74228.6837.0024.36
Other Liabilities44.3544.6343.4644.5141.8132.33
Total Liabilities2,474.872,503.852,435.792,617.732,433.802,474.20
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity506.98477.10424.71393.28385.49342.64
Total Shareholders Equity506.98477.10424.71393.28385.49342.64
Accumulated Minority Interest29.7829.3329.2627.1524.6424.74
Total Equity536.76506.42453.97420.43410.13367.38
Total Liabilities & Stockholders Equity3,011.643,010.282,889.763,038.162,843.932,841.58
Book Value Per Share4.013.743.323.063.012.67
Tangible Book Value Per Share-9.51-9.69-10.12-10.33-10.51-10.89
Full-Time Employees---13,133--
Price to Book Ratio10.658.967.026.547.838.58
Return on Assets7.266.716.305.805.765.74
Return on Equity47.6347.8948.3549.7546.2118.79
Return on Invested Capital2.542.542.021.441.991.84
Quick Ratio1.301.381.261.141.201.18
Current Ratio1.301.381.261.141.201.18

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income67.7767.3052.2936.1949.8246.19
Depreciation20.1519.9019.6520.2919.9119.00
Other Funds (Non Cash)5.835.675.184.582.624.38
Funds from Operations92.1790.5477.9359.7983.7268.39
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-40.3044.67-56.9158.90-23.0919.99
Cash from Operating Activities51.87135.2121.02118.6960.6388.38
Capital Expenditures-22.47-15.66-11.09-20.17-21.21-25.23
Net Assets From Acquisitions-6.240.00-3.760.000.00-54.28
Sale of Fixed Assets and Businesses2.821.470.000.040.740.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-25.88-14.20-14.85-20.13-20.47-79.51
Cash Dividends Paid-7.97-7.99-8.02-8.04-8.01-16.02
Preferred Dividends (Cash Flow)0.000.000.00---
Change in Capital Stock-34.65-10.96-15.00-22.420.000.00
Repurchase of Common Pref Stock-34.65-10.96-15.00-22.420.000.00
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-53.80-3.800.41-38.87-54.4230.92
Change in Long Term Debt-53.80-3.800.41-38.87-54.4230.92
Issuance of Long Term Debt0.000.004.910.000.0035.11
Reduction of Long Term Debt-53.80-3.80-4.50-38.87-54.42-4.18
Net Financing Active Other Cash Flow-1.79-1.93-1.770.73-1.66-2.01
Other Financing Activities Uses-1.79-1.93-1.77-2.13-1.66-2.01
Cash from Financing Activities-98.21-24.67-24.37-68.60-64.0912.89
Net Change in Cash-72.2296.34-18.2029.96-23.9321.76
Free Cash Flow29.40119.559.9398.5239.4263.15
Price to Free Cash Flow19.4116.1516.1215.3418.68-

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-301.93%2.3M117.7M1.04M
2026-10-153.04%3.6M118.6M970.34K
2026-09-303.05%3.6M118.6M933.52K
2026-09-152.76%3.2M115.3M920.70K
2026-08-312.43%2.8M115.3M952.74K
2026-08-141.94%2.2M114.3M958.12K
2026-07-312.75%3.1M114.1M962.52K
2026-07-152.95%3.4M114.5M919.64K
2026-06-302.49%2.9M114.5M846.26K
2026-06-152.32%2.7M114.3M804.74K
2026-05-292.33%2.7M114.5M771.90K
2026-05-151.94%2.2M114.3M788.38K
2026-04-302.52%2.9M114.3M818.34K
2026-04-152.11%2.4M114.8M905.06K
2026-03-312.31%2.7M114.9M952.94K
2026-03-132.39%2.7M114.9M925.12K
2026-02-272.06%2.4M114.9M957.98K
2026-02-132.41%2.8M114.4M959.49K
2026-01-303.00%3.4M114.4M980.48K
2026-01-152.56%2.9M114.4M919.78K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call20.000.000.000.00-0.000.00---
call22.500.000.000.00-0.000.00---
call25.000.000.000.00-0.000.00---
call30.000.000.008.00-1.000.00---
call35.000.000.005.30-5.000.00---
call40.000.000.002.20-1550.00---
call45.000.000.000.34-21.000.00---
call50.000.000.000.05-50.000.00---
put20.000.000.000.00-0.000.00---
put22.500.000.000.00-0.000.00---
put25.000.000.000.00-0.000.00---
put30.000.000.000.09-1,3520.00---
put35.000.000.000.50-11.000.00---
put40.000.000.000.49-1,3580.00---
put45.000.000.000.00-0.000.00---
put50.000.000.000.00-0.000.00---

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-108-KCurrent report2026-11-06SEC
2026-11-10SCHEDULE 13D/ASEC
2026-11-104Statement of changes in beneficial ownership of securities2026-11-06SEC
2026-11-098-KCurrent report2026-11-03SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-054Statement of changes in beneficial ownership of securities2026-11-03SEC
2026-11-054Statement of changes in beneficial ownership of securities2026-11-03SEC
2026-11-054Statement of changes in beneficial ownership of securities2026-11-03SEC
2026-11-054Statement of changes in beneficial ownership of securities2026-11-03SEC
2026-11-054Statement of changes in beneficial ownership of securities2026-11-03SEC
2026-11-054Statement of changes in beneficial ownership of securities2026-11-03SEC
2026-11-054Statement of changes in beneficial ownership of securities2026-11-03SEC
2026-11-054Statement of changes in beneficial ownership of securities2026-11-03SEC
2026-11-054Statement of changes in beneficial ownership of securities2026-11-03SEC
2026-11-054Statement of changes in beneficial ownership of securities2026-11-03SEC
2026-11-054Statement of changes in beneficial ownership of securities2026-11-03SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-08004.14M1
2026-07003.96M1
2026-06003.25M1
2026-05003.25M1
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
BlackRock, Inc.13.87%
PRICE T ROWE ASSOCIATES INC /MD/13.84%
VANGUARD PORTFOLIO MANAGEMENT LLC5.33%
VANGUARD CAPITAL MANAGEMENT LLC4.01%
STATE STREET CORP3.78%
GEODE CAPITAL MANAGEMENT, LLC2.66%
JENNISON ASSOCIATES LLC2.54%
DIMENSIONAL FUND ADVISORS LP2.54%
Invesco Ltd.2.28%
JPMORGAN CHASE & CO2.17%

Funds

Fund% owned
T. Rowe Price Mid-Cap Value Fund, Inc.5.77%
iShares Core S&P Small-Cap ETF5.60%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.85%
iShares Russell 2000 ETF2.37%
VANGUARD SMALL-CAP INDEX FUND2.07%
Invesco Small Cap Value Fund1.90%
Empower High Yield Bond Fund1.83%
VANGUARD SMALL-CAP VALUE INDEX FUND1.31%
High Income Fund1.17%
VANGUARD EXTENDED MARKET INDEX FUND1.07%

OakChart. CON. Cached 15 minutes.